Stock Ratings / Materials / GEVO / insiders

OEC (52) ALTO (48) ASPI (38) NL (44) ⌘ Pro Terminal →

Gevo Inc. (GEVO) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Q: Is GEVO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Gevo Inc. (NASDAQ: GEVO) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 29/100 at a spot price of $1.21 (-0.82% 1D, market cap $299.2M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, GEVO ranks #260 in composite RQD confidence.

Q: How does GEVO compare to OEC and ALTO in the Materials sector?

Within the Materials sector (Major Chemicals), GEVO carries a Roarable E (29/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -2.9%. By comparison, OEC (Orion S.A.) holds a D+ grade (52/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M) and ALTO (Alto Ingredients Inc.) posts a D grade (48/100 RQD, P/E N/A, ROIC 2.0%, cap $283.1M). Among the 5-stock peer group, GEVO leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for GEVO?

Per GEVO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001392380), Gevo Inc. generated $160.6M in revenue (+849.3% YoY), -$33.8M in net income, and -$43.5M in free cash flow against $718.9M in total assets and $164.8M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is GEVO trading relative to its 50-day, 200-day, and 52-week technical levels?

GEVO last traded at $1.21 (-0.82% on volume of 1,863,237 shares), positioning the stock -14.18% below its 50-day simple moving average ($1.41) and -29.65% below its 200-day simple moving average ($1.72). Across its 52-week range of $1.09 to $2.97, GEVO sits at the 6.4% percentile with a 14-day RSI of 48.2 (NEUTRAL RANGE) and an implied next-earnings move of ±11.2% ($1.07 to $1.35).

Q: Are GEVO insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies GEVO leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

$1.21 -0.82% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.21

Gevo Inc. (GEVO) carries a Roarable Rating of E (Strong Sell) with 29/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (29/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $299.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.21 (-0.34%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (29/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.8% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-13.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for GEVO)Realized 20D OHLCV Swing Band: ±11.2%

Deterministic 5-Pillar Attribution (29/100 Composite)

🔍 WHY GEVO SCORES 29/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (28% of score)

Altman Z-Score 0.20 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (28% of score)

FRED Regime × Technicals: 6% of 52W Range • RSI-14 at 48.2 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.32-11.4% Next Q

Q2 (-2Q)

Grade E$1.17-0.9% Next Q

Q3 (-1Q)

Grade E$1.16+4.3% Next Q

Current

Grade E$1.21-9.8% Hist 90D α

Trajectory: E (37) → E (29)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a GEVO Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While GEVO currently carries a cautious 29/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Materials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.41) and Max Pain ($1.27) forces dealer call-delta covering toward $3.12.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $GEVO• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “GEVO Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 29%NO 71%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

GEVO Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (GEVO)

No recent open-market Form 4 cluster sales or emergency dumps flagged on GEVO. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GEVO)

✓Walkthrough of GEVO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

GEVO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -36.65%▼ DESCENDING CHANNEL

2026-10-30O $1.20H $1.26L $1.19C $1.21VOL 2.95M

RES: $1.52SUP: $1.04SMA50: $1.41SMA200: $1.72

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

GEVO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 GEVO Butterfly Map → + Track GEVO →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on GEVO today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for GEVO. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for GEVO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GEVO)

Materials Rank #260 of 270 ⚔️ OEC vs GEVO Full Matrix →

1. Head-to-Head Materials Peer Comparison (GEVO vs. OEC, ALTO, ASPI, NL)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Gevo Inc. (GEVO) ranks #260 by composite RQD confidence (29/100, grade E) and #202 by equity capitalization ($299.2M). Within this direct 5-issuer industry benchmark cohort, GEVO leads on earnings valuation at N/A trailing P/E, while NL leads on capital efficiency and profitability with 3.4% ROIC and 30.4% gross margin. OEC currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with GEVO at 29/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
GEVO ACTIVE Gevo Inc.	E	29/100	—	—	-2.9%	-0.82%	$299.2M	Benchmark Subject
OEC Orion S.A.	D+	52/100	—	19.9%	2.2%	+1.28%	$313.1M	/oec-vs-gevo →
ALTO Alto Ingredients Inc.	D	48/100	—	3.8%	2.0%	-0.27%	$283.1M	/alto-vs-gevo →
ASPI ASP Isotopes Inc.	D-	38/100	—	14.3%	-35.0%	+4.93%	$326.5M	/aspi-vs-gevo →
NL NLI Holdings Inc.	D	44/100	—	30.4%	3.4%	-0.71%	$341.8M	/nl-vs-gevo →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001392380

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Gevo Inc. (GEVO) reported GAAP revenue of $160.6M (+849.3% vs. FY2024 revenue of $16.9M , and +833.6% cumulative change since FY2023) , GAAP net income of -$33.8M, operating cash flow of -$13.4M, and free cash flow of -$43.5M (+59.9% YoY). On the balance sheet, GEVO closed FY2025 with $718.9M in total assets against $164.8M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$160.6M	-$33.8M	-$13.4M	-$43.5M	$718.9M	$164.8M
FY2024 (FY)	2024-12-31	$16.9M	-$78.6M	-$57.4M	-$108.5M	$583.9M	$67.1M
FY2023 (FY)	2023-12-31	$17.2M	-$66.2M	-$53.7M	-$53.7M	—	—

3. GEVO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is GEVO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Gevo Inc. (NASDAQ: GEVO) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 29/100 at a spot price of $1.21 (-0.82% 1D, market cap $299.2M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, GEVO ranks #260 in composite RQD confidence.

How does GEVO compare to OEC and ALTO in the Materials sector?

Within the Materials sector (Major Chemicals), GEVO carries a Roarable E (29/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -2.9%. By comparison, OEC (Orion S.A.) holds a D+ grade (52/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M) and ALTO (Alto Ingredients Inc.) posts a D grade (48/100 RQD, P/E N/A, ROIC 2.0%, cap $283.1M). Among the 5-stock peer group, GEVO leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for GEVO?

Per GEVO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001392380), Gevo Inc. generated $160.6M in revenue (+849.3% YoY), -$33.8M in net income, and -$43.5M in free cash flow against $718.9M in total assets and $164.8M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is GEVO trading relative to its 50-day, 200-day, and 52-week technical levels?

GEVO last traded at $1.21 (-0.82% on volume of 1,863,237 shares), positioning the stock -14.18% below its 50-day simple moving average ($1.41) and -29.65% below its 200-day simple moving average ($1.72). Across its 52-week range of $1.09 to $2.97, GEVO sits at the 6.4% percentile with a 14-day RSI of 48.2 (NEUTRAL RANGE) and an implied next-earnings move of ±11.2% ($1.07 to $1.35).

GEVO Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are GEVO insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies GEVO leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: GEVO RQD Cockpit GEVO 12M Forecast GEVO Earnings & Move GEVO Dividends & DRIP GEVO Insiders & 13F GEVO Whale Options GEVO Profit Sankey GEVO News & Why